Evogene Ltd. (EVGN)
NASDAQ: EVGN · Real-Time Price · USD
0.7810
-0.0104 (-1.31%)
May 7, 2026, 4:00 PM EDT - Market closed
Evogene Revenue
In the year 2025, Evogene had annual revenue of $3.85M, down -30.91%. Evogene had revenue of $314.00K in the quarter ending December 31, 2025.
Revenue (ttm)
$3.85M
Revenue Growth
-30.91%
P/S Ratio
2.23
Revenue / Employee
$74,096
Employees
52
Market Cap
8.58M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 3.85M | -1.72M | -30.91% |
| Dec 31, 2024 | 5.58M | 2.60M | 87.02% |
| Dec 31, 2023 | 2.98M | 1.31M | 78.03% |
| Dec 31, 2022 | 1.68M | 745.00K | 80.11% |
| Dec 31, 2021 | 930.00K | -110.00K | -10.58% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Bolt Biotherapeutics | 7.70M |
| Xenetic Biosciences | 2.98M |
| BioAtla | 2.00M |
| XTL Biopharmaceuticals | 968.00K |
| Can-Fite BioPharma | 405.00K |
| Creative Medical Technology Holdings | 6.00K |
| Ernexa Therapeutics | 1,000.00 |
EVGN News
- 23 hours ago - Evogene Schedules First Quarter 2026 Financial Results Release - PRNewsWire
- 5 weeks ago - Evogene (EVGN) Faces Nasdaq Compliance Challenge Over Bid Price - GuruFocus
- 5 weeks ago - Evogene Reports Receipt of Nasdaq Minimum Bid Price Notification - PRNewsWire
- 5 weeks ago - Casterra Announces Successful Commercial Field Trials in Brazil, Positioning Castor Oil as a Promising Candidate for Economically Viable Biofuel Feedstock - PRNewsWire
- 7 weeks ago - Evogene Ltd (EVGN) Q4 2025 Earnings Call Highlights: Strategic Shifts Amid Revenue Decline - GuruFocus
- 7 weeks ago - Q4 2025 Evogene Ltd Earnings Call Transcript - GuruFocus
- 2 months ago - Evogene to Present Its Pharma Discovery Achievements at BIO-Europe Spring 2026 - PRNewsWire
- 2 months ago - Evogene Earnings Call Transcript: Q4 2025 - Transcripts